Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by flyinghorseon Feb 01, 2013 1:10pm

241 Views

Post# 20925362

RE: RE: RE: RE: RE: Beware

short term players are parasites? I suggest you open your dictionary and take a real hard look at its definition before you start using it. If someone sits on a stock, too lazy to move, thinking about a big payday every day, while riding up and down, lots of excitement yet always empty-handed, well, who looks more like a parasite?

If you have a point, please say it with respect and dignity. Don't resort to personal attacks and name calling. That goes to everyone who does that. BTW, in my investing experience, 9 out of 10 times I lost money was due to pumpers, not bashers.

Bullboard Posts

What will the U.S. election results mean for Canada?